HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Erica B Lee Selected Research
Erica B Lee Research Topics
Disease
30
Psoriasis (Pustulosis Palmaris et Plantaris)
08/2022 - 03/2018
3
Atopic Dermatitis (Atopic Eczema)
12/2023 - 03/2019
2
Dermatitis
12/2023 - 01/2021
2
Inflammation (Inflammations)
01/2019 - 01/2019
1
Drug-Related Side Effects and Adverse Reactions
12/2023
1
Muscular Atrophy (Muscle Atrophy)
07/2023
1
Systemic Mastocytosis
09/2022
1
Hypersensitivity (Allergy)
09/2022
1
Annular Erythema
09/2022
1
Contact Dermatitis (Eczema, Contact)
01/2021
1
Skin Neoplasms (Skin Cancer)
01/2021
1
Allergic Contact Dermatitis
01/2021
1
COVID-19
01/2021
1
Neoplasms (Cancer)
01/2021
1
Invasive Fungal Infections
10/2020
1
Mycoses (Diseases, Fungus)
10/2020
1
Herpes Zoster
06/2020
1
Asthma (Bronchial Asthma)
06/2020
1
Psoriatic Arthritis
06/2020
1
Ankylosing Spondylitis
06/2020
1
Infections
06/2020
1
Rheumatoid Arthritis
06/2020
1
Pemphigus (Pemphigus Vulgaris)
01/2020
1
Cerebral Toxoplasmosis
01/2020
1
Pain (Aches)
08/2019
1
Lentigo (Lentiginosis)
01/2019
1
Skin Manifestations
01/2019
1
Tuberculosis (Tuberculoses)
11/2018
1
Latent Tuberculosis
11/2018
Drug/Important Bio-Agent (IBA)
4
Cytokines
IBA
08/2022 - 01/2019
4
Interleukin-17 (Interleukin 17)
IBA
10/2020 - 01/2019
4
Interleukin-23 (Interleukin 23)
IBA
10/2020 - 01/2019
3
secukinumab
IBA
06/2020 - 01/2019
3
ixekizumab
IBA
06/2020 - 01/2019
3
Tumor Necrosis Factor Inhibitors
IBA
02/2020 - 09/2018
2
dupilumab
IBA
12/2023 - 02/2022
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
08/2020 - 04/2020
2
Biosimilar Pharmaceuticals
IBA
08/2020 - 04/2020
2
Etanercept (Enbrel)
FDA Link
08/2020 - 11/2018
2
Adalimumab (Humira)
FDA Link
08/2020 - 11/2018
2
brodalumab
IBA
06/2020 - 03/2019
2
guselkumab
IBA
01/2020 - 01/2019
2
apremilast
IBA
10/2018 - 10/2018
1
Interleukin-4 Receptors (Interleukin 4 Receptor)
IBA
12/2023
1
Immunosuppressive Agents (Immunosuppressants)
IBA
12/2023
1
Tryptases (Tryptase)
IBA
09/2022
1
Antigens
IBA
09/2022
1
Allergens
IBA
01/2021
1
Vitamin D
FDA Link
Generic
12/2020
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
12/2020
1
Local Anti-Infective Agents (Antiseptics)
IBA
12/2020
1
Immunologic Factors (Immunomodulators)
IBA
12/2020
1
Interleukin Inhibitors
IBA
10/2020
1
Interleukin-12 (IL 12)
IBA
10/2020
1
Infliximab (Remicade)
FDA Link
08/2020
1
CT-P13
IBA
08/2020
1
Rituximab (Mabthera)
FDA Link
01/2020
1
Phosphodiesterase 4 Inhibitors
IBA
03/2019
1
Type 4 Cyclic Nucleotide Phosphodiesterases
IBA
03/2019
1
crisaborole
IBA
03/2019
1
Antibodies
IBA
03/2019
1
Calcitonin Gene-Related Peptide
IBA
01/2019
1
Substance P
IBA
01/2019
1
Interleukins
IBA
01/2019
1
Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))
IBA
01/2019
1
Neuropeptides
IBA
01/2019
1
Nerve Growth Factor (NGF)
IBA
01/2019
1
tildrakizumab
IBA
01/2019
1
Steroids
IBA
07/2018
1
Janus Kinase Inhibitors
IBA
03/2018
Therapy/Procedure
14
Therapeutics
12/2023 - 03/2018
3
Biological Therapy
08/2020 - 03/2018
2
Phototherapy (Light Therapy)
11/2020 - 01/2019
1
Denervation
07/2023
1
Transplantation
07/2023
1
Personal Protective Equipment
01/2021
1
Dermatologic Surgical Procedures
01/2021
1
Mohs Surgery (Mohs' Micrographic Surgery)
01/2021
1
Lasers (Laser)
11/2020
1
Excimer Lasers
11/2020
1
Contraindications
08/2019